Sven Grösgen

1.3k total citations
17 papers, 1.0k citations indexed

About

Sven Grösgen is a scholar working on Physiology, Molecular Biology and Oncology. According to data from OpenAlex, Sven Grösgen has authored 17 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Physiology, 11 papers in Molecular Biology and 3 papers in Oncology. Recurrent topics in Sven Grösgen's work include Alzheimer's disease research and treatments (16 papers), Peroxisome Proliferator-Activated Receptors (4 papers) and Drug Transport and Resistance Mechanisms (3 papers). Sven Grösgen is often cited by papers focused on Alzheimer's disease research and treatments (16 papers), Peroxisome Proliferator-Activated Receptors (4 papers) and Drug Transport and Resistance Mechanisms (3 papers). Sven Grösgen collaborates with scholars based in Germany, Finland and Netherlands. Sven Grösgen's co-authors include Marcus O.W. Grimm, Tobias Hartmann, Heike S. Grimm, Benjamin Hundsdörfer, Tatjana L. Rothhaar, Verena K. Burg, Markus J. Riemenschneider, Viola J. Haupenthal, Heikki Tanila and Janine Mett and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Neuroscience and PLoS ONE.

In The Last Decade

Sven Grösgen

17 papers receiving 998 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sven Grösgen Germany 16 596 474 178 147 117 17 1.0k
Viola J. Haupenthal Germany 15 535 0.9× 352 0.7× 123 0.7× 109 0.7× 122 1.0× 18 891
Tatjana L. Rothhaar Germany 13 477 0.8× 382 0.8× 181 1.0× 142 1.0× 91 0.8× 15 822
Benjamin Hundsdörfer Germany 13 469 0.8× 359 0.8× 168 0.9× 125 0.9× 105 0.9× 15 794
Janine Mett Germany 15 529 0.9× 333 0.7× 148 0.8× 118 0.8× 121 1.0× 20 898
Catherine Malaplate‐Armand France 17 521 0.9× 438 0.9× 135 0.8× 143 1.0× 184 1.6× 30 1.0k
Dana M. Niedowicz United States 16 578 1.0× 427 0.9× 101 0.6× 55 0.4× 119 1.0× 26 1.3k
Gurdeep Marwarha United States 18 282 0.5× 408 0.9× 112 0.6× 219 1.5× 89 0.8× 34 967
Hanna Shevalye United States 23 586 1.0× 309 0.7× 110 0.6× 69 0.5× 136 1.2× 40 1.2k
Yu Hong United States 17 545 0.9× 568 1.2× 255 1.4× 114 0.8× 187 1.6× 31 1.5k
Ilaria Luccarini Italy 19 565 0.9× 436 0.9× 140 0.8× 143 1.0× 204 1.7× 20 1.4k

Countries citing papers authored by Sven Grösgen

Since Specialization
Citations

This map shows the geographic impact of Sven Grösgen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sven Grösgen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sven Grösgen more than expected).

Fields of papers citing papers by Sven Grösgen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sven Grösgen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sven Grösgen. The network helps show where Sven Grösgen may publish in the future.

Co-authorship network of co-authors of Sven Grösgen

This figure shows the co-authorship network connecting the top 25 collaborators of Sven Grösgen. A scholar is included among the top collaborators of Sven Grösgen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sven Grösgen. Sven Grösgen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Zimmer, Valerie C., Anna Andrea Lauer, Viola J. Haupenthal, et al.. (2023). A bidirectional link between sulfatide and Alzheimer’s disease. Cell chemical biology. 31(2). 265–283.e7. 7 indexed citations
2.
Grimm, Marcus O.W., Anna Andrea Lauer, Sven Grösgen, et al.. (2019). Profiling of Alzheimer’s disease related genes in mild to moderate vitamin D hypovitaminosis. The Journal of Nutritional Biochemistry. 67. 123–137. 18 indexed citations
3.
Grimm, Marcus O.W., Benjamin Hundsdörfer, Sven Grösgen, et al.. (2014). PS Dependent APP Cleavage Regulates Glucosylceramide Synthase and is Affected in Alzheimer's Disease. Cellular Physiology and Biochemistry. 34(1). 92–110. 26 indexed citations
4.
Burg, Verena K., Heike S. Grimm, Tatjana L. Rothhaar, et al.. (2013). Plant Sterols the Better Cholesterol in Alzheimer's Disease? A Mechanistical Study. Journal of Neuroscience. 33(41). 16072–16087. 97 indexed citations
5.
Grimm, Marcus O.W., Johannes Lehmann, Janine Mett, et al.. (2013). Impact of Vitamin D on Amyloid Precursor Protein Processing and Amyloid-β Peptide Degradation in Alzheimer's Disease. Neurodegenerative Diseases. 13(2-3). 75–81. 48 indexed citations
6.
Reinhardt, Sven, Florian Schuck, Sven Grösgen, et al.. (2013). Unfolded protein response signaling by transcription factor XBP‐1 regulates ADAM10 and is affected in Alzheimer's disease. The FASEB Journal. 28(2). 978–997. 80 indexed citations
7.
Grimm, Marcus O.W., Viola J. Haupenthal, Tatjana L. Rothhaar, et al.. (2013). Effect of Different Phospholipids on α-Secretase Activity in the Non-Amyloidogenic Pathway of Alzheimer’s Disease. International Journal of Molecular Sciences. 14(3). 5879–5898. 33 indexed citations
8.
Grösgen, Sven, Janine Mett, Valerie C. Zimmer, et al.. (2013). Upregulation of PGC‐1α expression by Alzheimer's disease‐associated pathway: presenilin 1/amyloid precursor protein (APP)/intracellular domain of APP. Aging Cell. 13(2). 263–272. 45 indexed citations
9.
Rothhaar, Tatjana L., Sven Grösgen, Viola J. Haupenthal, et al.. (2012). Plasmalogens Inhibit APP Processing by Directly Affectingγ-Secretase Activity in Alzheimer’s Disease. The Scientific World JOURNAL. 2012. 1–15. 61 indexed citations
10.
Grimm, Marcus O.W., Eva G. Zinser, Sven Grösgen, et al.. (2012). Amyloid Precursor Protein (APP) Mediated Regulation of Ganglioside Homeostasis Linking Alzheimer's Disease Pathology with Ganglioside Metabolism. PLoS ONE. 7(3). e34095–e34095. 48 indexed citations
11.
Grimm, Marcus O.W., Sven Grösgen, Verena K. Burg, et al.. (2011). Docosahexaenoic Acid Reduces Amyloid β Production via Multiple Pleiotropic Mechanisms. Journal of Biological Chemistry. 286(16). 14028–14039. 180 indexed citations
12.
Grimm, Marcus O.W., Tatjana L. Rothhaar, Sven Grösgen, et al.. (2011). Plasmalogen synthesis is regulated via alkyl‐dihydroxyacetonephosphate‐synthase by amyloid precursor protein processing and is affected in Alzheimer’s disease. Journal of Neurochemistry. 116(5). 916–925. 88 indexed citations
13.
Grimm, Marcus O.W., Tatjana L. Rothhaar, Sven Grösgen, et al.. (2011). Trans fatty acids enhance amyloidogenic processing of the Alzheimer amyloid precursor protein (APP). The Journal of Nutritional Biochemistry. 23(10). 1214–1223. 61 indexed citations
14.
Grimm, Marcus O.W., Sven Grösgen, Tatjana L. Rothhaar, et al.. (2011). Intracellular APP Domain Regulates Serine‐Palmitoyl‐CoA Transferase Expression and Is Affected in Alzheimer′s Disease. International Journal of Alzheimer s Disease. 2011(1). 695413–695413. 48 indexed citations
15.
Grimm, Marcus O.W., Sven Grösgen, Markus J. Riemenschneider, et al.. (2011). From brain to food: Analysis of phosphatidylcholins, lyso-phosphatidylcholins and phosphatidylcholin–plasmalogens derivates in Alzheimer's disease human post mortem brains and mice model via mass spectrometry. Journal of Chromatography A. 1218(42). 7713–7722. 97 indexed citations
16.
Grösgen, Sven, et al.. (2010). Role of amyloid beta in lipid homeostasis. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1801(8). 966–974. 64 indexed citations
17.
Zimmermann, Martina, Sven Grösgen, Martin S. Westwell, & Susan A. Greenfield. (2007). Selective enhancement of the activity of C‐terminally truncated, but not intact, acetylcholinesterase. Journal of Neurochemistry. 104(1). 221–232. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Viola J. Haupenthal Breakdown of academic impact, for papers by Tatjana L. Rothhaar Breakdown of academic impact, for papers by Benjamin Hundsdörfer Breakdown of academic impact, for papers by Janine Mett Breakdown of academic impact, for papers by Catherine Malaplate‐Armand Breakdown of academic impact, for papers by Dana M. Niedowicz Breakdown of academic impact, for papers by Gurdeep Marwarha Breakdown of academic impact, for papers by Hanna Shevalye Breakdown of academic impact, for papers by Yu Hong Breakdown of academic impact, for papers by Ilaria Luccarini
Rankless by CCL
2026